SPI Pharma: Your Formulation Partner in Vaccine Innovation
SPI Pharma is a global leader in delivering specialized formulation and delivery solutions that support both human and veterinary vaccine development.
Our comprehensive portfolio includes vaccine adjuvants, high-performance excipients, and advanced delivery technologies, all designed to enhance vaccine efficacy, stability, and patient compliance. From early-stage R&D through commercial production, we partner closely with manufacturers to overcome complex formulation challenges and bring innovative vaccines to market faster.
Whether you're working on next-generation platforms like mRNA or improving established delivery systems, SPI Pharma offers the technical expertise and collaborative support to accelerate your success.
Join us at World Vaccine Congress Europe 2025 to discover how our latest solutions can support your next breakthrough in vaccine development.